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ABSTRACT  
Objective: Evaluate and compare the research contributions of Community Pharmacy Foundation (CPF) funding on community 
pharmacy practice innovation between non-academic and academic principal investigators (PIs) with respect to the following 
measurements: 1) “Pharmacy Practice Activity Classifications” (PPAC); 2) CPF “Coordinated Use of Medications”; and 3) CPF 
Investigator Impact. 
Methods: Quantitative data for all 124 CPF-funded grants awarded from 2002-2016 were obtained from the CPF website and 
personnel, while ethnographic qualitative data was generated from queries of PIs. Grant categorization was conducted by 
researchers serving as judges trained on the rules and procedures for coding.  A threshold level of 90% agreement in scores of 
independent judging was established a priori.  Findings were summarized and groups were compared using descriptive statistics for 
quantitative data and a thematic analysis of PI ethnographic reflections for qualitative data.  
Results: There were no differences between non-academic and academic PI groups for Coordinated Use of Medications and PPAC 
domains, but non-academics contributed more to two dispensing-related PPAC subclasses: ‘Preparing the Product’ (10% vs. 2%) and 
‘Delivering the Medication or Device’ (13% vs. 2%).  Analysis of investigator reflections revealed similarities between groups 
regarding impact on practice innovations, expanded collaborations, new practice tools, and patient-care financing models.    
Conclusions: CPF funding contributed new knowledge and resources for expanding and enhancing practice innovations as shown by 
quantitative (PPAC & Coordinated Use of Medications) and qualitative (PI impact) measures.  Similarities between PI groups suggest 
that the CPF has established a funding niche with unique diversity of practice innovation opportunities. This investigation’s findings 
may be useful to the CPF’s continuous quality improvement efforts, as well as future grant applicants to assess research gaps in the 
medication use process and develop sustainable, transferable, and replicable patient-care innovations in community pharmacy 
practice.   
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INTRODUCTION 
The Community Pharmacy Foundation (CPF) is a non-profit 
organization that has awarded over $7,900,000 in research 
and development grants for advancing community pharmacy 
practice and patient care delivery improvement since 2002.1  
In June 2015, the CPF collaborated with University of 
Minnesota researchers to analyze the scope and impact of all 
funded grants for use by the Foundation to evaluate its past 
funding decisions and guide future grant making, as well as 
for grantees to identify potential enhancements and research 
gaps.2  Defined as Phase 0, the CPF Program Evaluation 
Project was a global overview of CPF funding and described 
grants by topic, funding level, and other criteria.  It compared 
the data between two time periods, the ‘Initial Years’ (2002-
2008) and ‘Recent Years’ (2009-2015), with respect to the 
Agency for Healthcare Research & Quality (AHRQ) Impact 
Factor, the Three-Part Aim adopted by the Centers for 
Medicare & Medicaid Services (CMS), and the CPF 
‘Coordinated Use of Medications’ frameworks. Qualitative 
data were also generated from principal investigator (PI) 
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reflections about the influence of CPF funding on practice 
innovation, career progression, collaborations, and 
subsequent funding.  Results demonstrated that the 
fulfillment of AHRQ, CMS, and CPF framework measures by 
projects had increased over time and that CPF funding was 
very important to the careers and development of the PIs 
receiving grants.  The project is summarized in a CPF Synopsis 
and American Pharmacists Association 2016 Annual Meeting 
poster on the CPF website.3  
 
After submission of the CPF Program Evaluation Project 
report to the CPF Board, two subsequent analyses were 
requested to identify characteristics of the two main grant 
applicants – academic primary investigators and non-
academics.   Phase I included grants completed during 
calendar years of 2002 – 2014 (N=107) for a subgroup 
analysis of the 58 grants to PIs receiving academic salary 
support (i.e. academics) to further evaluate the Foundation’s 
past and future funding decisions.  Furthermore, investigator 
impact evaluations were also conducted and included all 
grantees awarded between January 2002 – June 2015. 
Findings generated from the subgroup were consistent with 
trends identified in the original report and revealed an 
equitable distribution of grants with respect to academic 
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institution types (i.e. public vs. private) and geographic 
locations.2 
 
Phase II included a broadened time frame with grants 
approved and completed between January 2002 – March 
2016 (N=124) to capture additional quantitative and 
qualitative data with an emphasis on both non-academic 
(n=61) and academic (n=63) primary investigators and their 
research contribution similarities and differences, particularly 
with an emphasis on pharmacy practice.   This comparison 
was done to reveal general CPF funding patterns for the 
benefit of CPF-decision makers for these two predominant 
applicant types and also for researchers seeking financial 
support for their work.  For this reason, the Pharmacy 
Practice Activity Classifications (PPAC) was added as a new 
measure to the Phase II analysis to quantify practice-based 
patient care and pharmacy administration activities.  
 
Study Objectives 
The objectives of this evaluation were to compare non-
academic and academic PIs with respect to the following 
research contribution measures: 
1. “Pharmacy Practice Activity Classifications” (PPAC)  
2. CPF “Coordinated Use of Medications”  
3. CPF Investigator Impact  
 
METHODS 
Data Source & Variables 
Data originating from grants awarded from January 2002 
through March 2016 were obtained from the CPF website, 
CPF personnel, and CPF grant recipients.  PIs for CPF grants 
were categorized as: 1) non-academic (i.e., do not receive 
salary support from an academic institution) or 2) academic 
(i.e., receive salary support from an academic institution). PI 
categorization for all 124 CPF grants (total number completed 
at the time of this study) was conducted by one researcher 
(AO) using information from: 
www.communitypharmacyfoundation.org/grants/grants_list.
asp.   
 
Pharmacy Practice Activity Classifications (PPAC) 
The 124 CPF projects were quantitatively analyzed for 
contributions made to the PPAC, a taxonomy categorizing all 
pharmacists’ roles, responsibilities and activities into 14 
classes within four domains: 1) Appropriate Therapy and 
Outcomes, 2) Dispensing Medications and Devices, 3) Health 
Promotion and Disease Prevention, and 4) Health Systems 
Management.4–6  A complete description of the PPAC can also 
be found at: 
www.pharmacist.com/sites/default/files/pharmacy_practice_
activity_classification.pdf. 
 
Grant categorization within the PPAC framework was 
completed by three researchers (BI, AO, and JS) serving as 
judges trained on the rules and procedures for coding, and 
each judge independently scored the same 30 grants to 
establish and evaluate scoring consistency.  The coding 
process utilized a rigid interpretation of PPAC definitions 
where only grants that directly applied to pharmacists’ tasks 
and activities were assigned to the four PPAC Domains (i.e., 
scores of 1, 2, 3, or 4).  Grants that were not directly related 
to specific pharmacist activities in the PPAC taxonomy were 
labeled as ‘Not Applicable’ (NA).  Examples of grants coded 
‘NA’ were a manual for how to develop a residency program 
and a toolkit for selling a community pharmacy.  These 
projects tended to be collaborative projects with national 
professional associations, thereby negating their 
classifications into academic and non-academic.  After 
training, a threshold level of 90% agreement in scores of 
independent judging of these 30 grants was exceeded, and 
one researcher (AO) completed subsequent coding for this 
objective.   
 
Coordinated Use of Medications  
The 124 CPF projects were quantitatively analyzed for 
contributions made to the “Coordinated Use of Medications,” 
which is part of the CPF’s Strategic Interests Plan7 and defined 
as: 
1. Payment reform- Results that further the 
understanding, implementation, or evaluation of 
global or budgeted payment models that standardize 
and incentivize the indicated, effective, and safe use 
of medications, as well as engaged or adherent 
patients, to help meet quality health goals. 
2. Delivery reform- Results that further the 
understanding, implementation, or evaluation of 
new payment models with accreditation or other 
prerequisites, as well as competitive strategies for 
delivering medication-related care and services 
within such systems.  
3. Real-time data integration- Results that further the 
understanding, implementation, or evaluation of 
health information environments that make 
available standardized, comprehensive, and real-
time data at the point of care on the patient’s 
medication history and adherence that is crucial to 
effective and efficient medication use. 
 
Grant categorization within this framework was completed by 
two researchers (AO and JS) serving as judges trained on the 
rules and procedures for coding, and each judge 
independently scored the same 30 grants to establish and 
evaluate scoring consistency.  A threshold level of 90% score 
agreement for independent judging of these 30 grants was 
exceeded, and one researcher (AO) completed the remainder 
of coding for this objective. 
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CPF Investigator Impact  
Determination of Investigator Impact from CPF funding using 
PI reflections was conducted by one researcher (BI) using 
ethnographic observation methods8 utilizing a semi-
structured query to elicit PI responses. Data collection sought 
reflections from the 114 unique PI and co-PIs awarded a CPF 
grant from 2002 to June 2015 (Phase I) plus 17 PI’s awarded a 
CPF grant after June 2015 (Phase II).  It is noted that there 
were only 99 current e-mail addresses available for the CPF 
Phase I grantees, with the contact information for the 
remaining 15 investigators not able to be found. However, all 
17 CPF Phase II awardees had current and valid contact 
information.    Phase I queries (administered June 1st-July 
20th, 2015 as part of the CPF Program Evaluation Project) 
began with an emailed invitation asking investigators to 
reflect on how CPF funding helped them obtain subsequent 
funding, career advancement, honors and professional 
development, and influence on practice innovation. Phase I 
yielded 32 responses from academic PIs and 12 responses 
from non-academic PIs.   Phase II queries (administered 
October 28th - November 29th, 2016) were initiated 
specifically for this investigation and began with a new and 
distinct emailed invitation to the 17 Phase II CPF awardees 
and the 55 Phase I academic and non-academic non-
respondents.  The Phase II invitation asked grantees to 
specifically reflect on how CPF-funding helped them enhance 
or expand their practices. No additional academic responses 
were submitted with Phase II, so phases I and II combined to 
produce a total of 32 academic and 24 non-academic 
responses. 
 
Data Analysis 
Descriptive statistics were used to summarize and compare 
groups for objectives 1 and 2.  Inferential statistics were not 
used in analysis given the data were a census and not a 
sample. A thematic analysis of PI reflections was conducted 
(by BI) using a descriptive and interpretive ethnographic 
method.8,9  The comments were read multiple times and 
dominant themes were extracted by a single researcher (BI) 
and then discussed among and affirmed by the University of 
Minnesota research team (BI, JS, AO). 
 
RESULTS 
Pharmacy Practice Activity Classifications (PPAC) 
The 61 CPF grants completed by non-academic PIs were 
compared to 63 grants completed by academic PIs for their 
contributions toward PPAC domains. Table 1 shows that 59% 
of all CPF grants investigated an aspect of health promotion 
and disease prevention, followed by health systems 
management (52%), appropriate therapy and outcomes 
(51%), and dispensing medications and devices (16%). 
Overall, 24% of projects investigated one PPAC Domain, 26% 
investigated two, 23% investigated three, and 8% 
investigated all four.  There were 19% of all CPF grants that 
were coded as NA because they were not directly related to 
specific pharmacist activities in the PPAC taxonomy given 
their focus on topics like education, developing residency 
programs, implementing training grants, financially 
supporting the attendance of a conference, etc. rather than 
specific pharmacist tasks and activities.   
 
Projects with investigators who were academics had a higher 
percentage of projects that addressed at least one PPAC 
Domain-related contribution than their non-academic 
counterparts (i.e., 86% vs. 77%). However, non-academics 
had a higher proportion of completed grant projects that 
incorporated all four PPAC Domain-related contributions 
relative to their academic counterparts (i.e., 13% vs. 3%).   
 
Table 1 also shows slightly higher prevalence of grants from 
Domains B (i.e., Dispensing Medications & Devices) and C 
(Health Promotion & Disease Prevention) for non-academics 
than academics and different types of contributions by these 
groups within Domain D.  The trend in Domain B is due to a 
higher proportion of non-academics completing projects 
related to subclasses ‘Preparing the Product’ & ‘Delivering 
the Medication or Device’ than their academic counterparts.  
Similarly, the difference in Domain C can be attributed 
primarily to a higher proportion of non-academics completing 
projects related to ‘Promoting Safe Medication Use’ than 
their academic counterparts. For Domain D (i.e., Health 
Systems Management), projects completed by non-
academics more frequently addressed topics related to 
‘Managing the Practice’ and ‘Managing Medications in 
System,’ while academics displayed a higher proportion of 
completed projects that involved ‘Research Activities.’    
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Table 1: PPAC Contributions for Completed CPF Grants by Non-academic and Academic PIs. 
 
 
 
Non-Academic 
PIs 
N = 61 
Academic  
PIs 
N = 63 
Overall 
 
N = 124 
PPAC Domains & Subclasses  (% Yes) (% Yes) (% Yes) 
 
Domain A:      Appropriate Therapy & Outcomes  
        (Subclasses A1, A2, or A3) 
 
Subclass A1:  Appropriate Pharmacotherapy 
Subclass A2:  Patient Understanding & Adherence 
Subclass A3:  Monitoring & Reporting Outcomes 
       
 
49% 
 
 
46% 
39% 
38% 
 
52% 
 
 
43% 
40% 
32% 
 
51% 
 
 
44% 
40% 
35% 
 
 
Domain B:      Dispensing Medications & Devices 
        (Subclasses B1, B2, or B3) 
 
Subclass B1:  Processing the Prescription or Order 
Subclass B2:  Preparing the Product 
Subclass B3:  Delivering the Medication or Device 
 
 
20% 
 
 
8% 
10% 
13% 
 
13% 
 
 
8% 
2% 
3% 
 
16% 
 
 
8% 
6% 
8% 
 
 
Domain C:   Health Promotion & Disease Prevention 
      (Subclasses C1, C2, or C3) 
 
Subclass C1:  Clinical Preventative Services 
Subclass C2:  Pub. Health Surveillance & Reporting 
Subclass C3:  Promoting Safe Medication Use 
 
 
62% 
 
 
46% 
30% 
34% 
 
 
56% 
 
 
46% 
27% 
19% 
 
 
59% 
 
 
46% 
28% 
27% 
 
 
Domain D:      Health Systems Management 
         (Subclasses D1, D2, D3, D4, or D5) 
 
Subclass D1:  Managing the Practice 
Subclass D2:  Managing Medications in System 
Subclass D3:  Managing Medication Use in System 
Subclass D4:  Research Activities 
Subclass D5:  Interdisciplinary Collaboration 
 
 
54% 
 
 
44% 
12% 
23% 
13% 
33% 
 
 
51% 
 
 
32% 
3% 
25% 
21% 
33% 
 
 
52% 
 
 
38% 
7% 
24% 
17% 
33% 
 
 
Total Number of PPAC Domain Contributions  
(Domains A, B, C, or D) 
NA 
One 
Two 
Three 
Four 
 
 
 
 
23% 
16% 
26% 
21% 
13% 
 
 
 
14% 
32% 
25% 
25% 
3% 
 
 
 
19% 
24% 
26% 
23% 
8% 
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Coordinated Use of Medications 
The 61 CPF grants completed by non-academic PIs were 
compared to the 63 grants completed by academic-PIs for 
their contributions toward the CPF “Coordinated Use of 
Medications.”  The majority of the 124 completed projects 
contributed to research on Delivery Reform (68%), with few 
contributing to Payment Reform (11%) and Real Time Data 
Integration (11%) research.  Overall 61% of projects 
contributed to one category, 10% contributed to two, and 3% 
contributed to all three.  Table 2 shows no remarkable 
differences between non-academic and academic PIs overall, 
but there is a slightly higher prevalence of completed grant 
projects focused on ‘Delivery Reform’ for academics than 
there are for non-academics.  
 
 
Table 2: ‘Coordinated Use of Medications’ Contributions for Completed CPF Grants by Academic PIs and Non-Academic PIs. 
 
 
 
Non-Academic PIs 
N = 61 
Academic PIs 
N = 63 
Overall 
N = 124 
Coordinated Use of Medications (% Yes) (% Yes) (% Yes) 
 
Payment Reform  
 
 
13% 
 
10% 
 
11% 
 
Delivery Reform  
 
 
64% 
 
71% 
 
68% 
 
Real Time Data Integration  
 
 
12% 
 
10% 
 
11% 
 
Total Number of ‘Coordinated Use of 
Medications’ Contributions 
None 
One 
Two 
Three 
 
 
 
 
30% 
57% 
8% 
5% 
 
 
 
24% 
64% 
11% 
2% 
 
 
 
27% 
61% 
10% 
3% 
 
 
CPF Investigator Impact 
Table 3 summarizes the categories of investigator impact for 
non-academic and academic PIs.   The academic grantee 
responses are previously described.2 As a result of Phase I 
and II queries, there were 24 CPF non-academic grantees that 
provided reflections on how CPF funding helped enhance or 
expand practice, which resulted in four broad practice 
innovation themes: 
 
1. New and expanded patient care services, 
2. New and expanded collaborations, 
3. New tools/approaches to improve workflow and 
patient understanding of services, and 
4. New data/information supporting the business case 
for pharmacists’ practice innovations. 
 
Some respondents provided reflections that were categorized 
into multiple themes, producing 47 different practice 
innovation observations.  A descriptive response summary of 
the non-academics for each theme with the number of 
reflections noted in parentheses included: 
 
New and expanded patient care services (16/24) 
Specific examples of new and expanded patient care services 
facilitated through CPF funding included, pediatric 
immunizations, osteoporosis screening, remote monitoring of 
patients’ blood pressure and blood glucose readings, smoking 
cessation, diabetes care services, prenatal care, Lyme Disease 
prophylaxis, and team-based comprehensive medication 
management services.  
 
New and expanded collaborations (12/24) 
New and expanded collaborations facilitated through CPF 
funding included, health system and clinic-based 
collaborative practice agreements, managed care and health 
insurance partnerships, creation of educational materials to 
assist in advocacy for legislative initiatives, employer-based 
programs, and local and state health departments. 
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New tools and approaches to improve workflow and patient 
understanding of services (11/24) 
New tools and approaches to improve workflow and patient 
understanding of services included: community outreach 
resources, marketing plans, documentation standards, 
appointment scheduling communications, quality metrics, 
and a practice readiness inventory to guide service 
implementation. 
 
 
New data/information supporting the business case for 
pharmacists’ practice innovations (8/24) 
New data and information supporting the business case for 
pharmacist integration in care delivery and reimbursement 
reform included, a payer credentialing program, payment 
protocols for medication management services, community 
pharmacist integration in Accountable Care Organizations, a 
community-based medication management bundled 
payment, and a national campaign providing information 
influencing payers and policy-makers to get the medications 
right. 
 
 
Table 3: ‘CPF Investigator Impact’ for Completed CPF Grants by Academic PIs and Non-Academic PIs. 
 
 Non-Academic PIs Respondents 
N = 24 
Academic PIs Respondents 
N = 32* 
New and Expanded Patient Care 
Services/Practice Development 
66%  59% 
Promotion & Advancement -- 59% 
New & Expanded Collaborations 50%  38% 
Funding Opportunities -- 22% 
Awards -- 22% 
Tool/Resource Development 46% -- 
Reimbursement / Payment Reform 33% 9% 
--Blank responses indicate a response was not provided for that specific category.  
*Data available from:  Isetts BJ, Olson AW, Schommer JC, Kondic AM. An Evaluation of the Distribution, Scope, and Impact of Community 
Pharmacy Foundation Grants Completed by Academic Principal Investigators between 2002 and 2014. Inov Pharm. 2017;8(1): Article 24.2 
 
 
DISCUSSION 
Results of this investigation describes similarities and 
differences between the census of non-academic and 
academic PIs.  An almost equivalent grant distribution 
between these subgroups was ideal for such a comparison, 
with 49% of the CPF grants awarded to non-academic PIs and 
51% being awarded to academic PIs. This nearly identical split 
appears to reflect efforts by CPF to provide as many grants as 
possible to a diverse array of individuals, institutions and 
practice sites. The collaborative process for conducting this 
analysis can be viewed as generating a “report card” for CPF 
decision-makers to evaluate and reflect on funding decisions 
over the past 10 years. Results also demonstrate that CPF has 
been a vehicle for practitioner-driven practice innovation 
research that represents a funding alternative to government 
agencies (e.g., NIH, AHRQ, etc.). 
 
Pharmacy Practice Activity Classifications (PPAC) 
The first objective of this evaluation was to compare the 
research contributions of CPF grants awarded to non-
academic PIs and academic PIs. The affiliation or lack of 
affiliation of a PI with an academic institution revealed slight 
differences at the group level for PPAC domain fulfillment in 
terms of either type and number.  
 
Findings comparing domain-level differences between 
academic and non-academic comparator groups showed a 
higher proportion of the latter completing projects for 
‘Preparing the Product’ (B2), ‘Delivering the Medication or 
Device’ (B3), ‘Promoting Safe Medication Use’ (C3), 
‘Managing the Practice’ (D1), and ‘Managing Medications in 
the System’ (D2) relative to the former.  In contrast, 
academics completed a higher proportion of Health Systems 
Management ‘Research Activities’ (D4) than their non-
academic counterparts.  These findings suggest a greater 
emphasis on these domains and subclasses with slight 
differences between non-academics and academics in terms 
of salience and focus for different pharmacist activities. 
However, the size of these differences between non-
academic and academic PIs (i.e., all less than 15%) implies a 
similar approach with respect to other aspects of pharmacist 
practice. 
 
Descriptive comparisons between academics and non-
academics with respect to the number of PPAC domain 
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contributions for each respective grant showed a higher 
proportion of academics who addressed at least one PPAC 
domain compared to their non-academic counterparts.  
However, non-academics more frequently completed grants 
that contributed to all four PPAC domains compared to their 
academic colleagues. There are many potential reasons for 
the differences between these groups including training, 
research focus, and intervening variables related to the grant 
award process.  For instance, academics are generally trained 
to generate in depth, but very narrow scopes of investigation 
that may have led to fewer grants that addressed all four 
PPAC components.  In contrast, non-academics may have 
more pragmatic training in trying to address all relevant 
causes related to an issue (i.e., address all four domains of 
pharmacist activities) or focus on topics that indirectly 
support pharmacist activities, such as developing a residency 
program manual (i.e., NA).  There were also some academics 
with grants that scored ‘NA’ for topics, such as 
entrepreneurial leadership or a national census 
for community-based patient care services, but these were 
fewer in number and proportion.   
 
Another difference in the results may reflect a fewer number 
of academics conducting research in Domain B (e.g., 
Dispensing Medication and Devices) because their focus is on 
growing other aspects of pharmacist practice, while non-
academics still have dispensing as a critical component of 
their daily workflow. It’s also possible that an intervening 
variable could explain differences, such as some PIs classified 
as academics being in practice positions and others not. 
 
Finally, it is important to note that many of the grants 
analyzed did not fit well into the PPAC domains (e.g., 
education, residency programs, training grants, conference 
grants, etc.).  This exclusion pertains to their indirect 
relationship with the specific pharmacist tasks and activities 
segmented by the PPAC rather than their importance and 
value to the pharmacist community. For example, although a 
toolkit for how to sell a pharmacy or a manual for developing 
a PGY1 residency program manual is useful and important, 
they do not directly relate to ‘Ensuring Appropriate Therapy 
and Outcomes’ (Domain A), ‘Dispensing Medications and 
Devices’ (Domain B), ‘Health Promotion and Disease 
Prevention’ (Domain C), or Health Systems Management 
(Domain D). A more flexible interpretation of PPAC definitions 
that force-fit ‘NA’ rated grants into PPAC domains was 
possible, but would expand how other grants were coded and 
lead to a less meaningful analysis. 
 
Coordinated Use of Medications 
The second objective of this evaluation compares each 
respective group with respect to the CPF “Coordinated Use of 
Medications” strategic framework. PI affiliation with an 
academic or non-academic institution did not reveal 
remarkable differences in the ‘Coordinated Use of 
Medications’ framework.  Most grants in both groups 
contributed to Delivery Reform, with far fewer doing so for 
Payment Reform and Real Time Data Integration.   
Furthermore, the ‘Coordinated Use of Medications’-related 
achievement profiles of the respective comparison groups did 
not reveal remarkable differences for the total number (i.e., 
None, One, Two, Three) or type (Payment Reform, Delivery 
Reform, Data Integration).  This suggests that both academic 
and non-academic PIs perceived, focused, and acted within 
each component of this CPF identified framework at a very 
similar prevalence within this evaluation’s time frame. 
 
CPF Investigator Impact 
The third and final objective analyzed practice innovation 
contributions of CPF funding using PI reflections.   Thematic 
analysis yielded results from non-academic PIs that were 
consistent with and more descriptive than previous analyses.  
Both PI groups highlighted new and expanded collaborations 
with health system and clinic-based collaborative practice 
agreements, managed care and health insurance 
partnerships, legislative initiatives, employer-based 
programs, and local and state health departments with little 
discernable differences.  Similarly, both groups identified new 
data and information useful for supporting, providing, and 
reimbursing pharmacist practice innovations like medication 
reviews, pay for performance, shared-savings measures, and 
comprehensive medication management. Finally, the 
development and testing of new patient care services, public 
health communications tools, and quality metrics was a 
shared theme between the groups that extended across 
patient populations. Academics commented on areas of 
promotion, funding opportunities and awards which, in part, 
are measures of success and advancement in these settings.  
In contrast, non-academicians emphasized tools and resource 
development in their responses, which may reflect a focus on 
communities of learning and practical advancement.  
 
LIMITATIONS 
The interpretation of the results should account for 
limitations of this analysis.  The evaluation used observational 
methods and the thematic analysis of PI reflections were 
developed from a relatively low response rate (38.5%), which 
limits its generalizability and may have been subject to 
selection bias.  PIs who responded to requests for reflections 
about the research contributions of CPF funding may have 
perceived the grants more impactful or led to more 
successful results than non-responders.  Additionally, it 
should be noted that non-academic PIs may have had co-
investigators or support staff from academic institutions, and 
vice versa. This information was not accounted for in the 
analysis and may partially explain the lack of differences 
between non-academics and academics. 
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CONCLUSIONS 
CPF funding has contributed to new knowledge and tools as 
demonstrated by quantitative (i.e., Coordinated Use of 
Medications, PPAC) and qualitative (i.e., PI ethnographic 
reflections) measures regardless of whether PIs were 
classified as academic or non-academic.  Slight differences 
between the groups between and within PPAC Domains 
suggest potential differences in emphasis for non-academic 
PIs and academic PIs.  However, overall similarities between 
PI groups present an interesting snapshot that suggests CPF 
has established a unique funding niche with a diversity of 
practice innovation opportunities regardless of academic or 
non-academic affiliation. This investigation’s findings may be 
useful to the CPF’s continuous quality improvement efforts, 
as well as existing and future grant applicants, to assess 
research gaps in the medication use process and developing 
sustainable, transferable, and replicable patient-care 
innovations in community pharmacy practice.   
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